Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04599634 2025-02-04

Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies

Phase 1 Completed

11 enrolled 16 charts

Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03188354 2024-01-05

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Phase NA Completed

3 enrolled

CNSLymphoid

Lymphoma, Non-Hodgkin, Central Nervous System Neoplasms

NCT03212157 2021-09-29

GlucoCEST MRI in Oncology

Phase NA Completed

15 enrolled

CNSHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Glioma, Lymphoma

NCT01557881 2020-02-24

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

Phase NA Terminated

98 enrolled 5 charts

DermatologicGastrointestinalHead & NeckLymphoidThoracic

Colonic Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Neoplasms

NCT02733887 2016-04-12

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Phase NA Unknown

66 enrolled

Lymphoid

Lymphoma

Clinical Trials

PALS

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

Pediatric PET/MR Image Registry

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

GlucoCEST MRI in Oncology

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma